Whole-body Vibration on Mucus Clearance, the Quality of Life, and Exercise Capacity for Patients With Chronic Obstructive Pulmonary Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-12-22

Study Completion Date

2018-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Although whole body vibration (WBV) is mainly designed to promote neuromuscular function, however, because of its vibration characteristics, whether it can provide additional effects on the sputum clearance for chronic obstructive pulmonary (COPD) disease patients, thereby improving the quality of life, and exercise capacity is still unknown.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effects of Different Vibration Exercises on COPD Patients

NCT06413524

COPD COPD Chronic Obstructive Pulmonary Disease Vibration Therapy

RECRUITING NA

Whole Body Vibration in Chronic Obstructive Pulmonary Disease

NCT01850173

COPD

COMPLETED NA

Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Lung Disease

NCT01898143

Chronic Obstructive Lung Disease (n=10) Interstitial Lung Disease (n=10)

COMPLETED NA

Whole Body Vibration in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01649310

Chronic Obstructive Pulmonary Disease (COPD)

UNKNOWN NA

Vibration Training in Chronic Obstructive Pulmonary Disease (COPD)-Patients During a Three-week Rehabilitation

NCT01380652

Chronic Obstructive Pulmonary Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HFCWO+WBVT

Subjects received HFCWO+WBVT intervention twice a week for a period of 8 weeks

Group Type EXPERIMENTAL

A vertical vibration platform PowerVibe Zen Pro 5900

Intervention Type DEVICE

Subjects received the interventions twice a week for 8 weeks. HFCWO+WBVT group received additional 30 minutes WBVT treatment. In every WBVT session, three rounds of 3 minutes of vibration (amplitude: 2 mm; frequency: 20 Hz) were provided, with a 60-second rest between rounds.

HFCWO

Intervention Type DEVICE

Subjects received the interventions twice a week for 8 weeks. The HFCWO was delivered by a respiratory therapist using a percussive vest at 10-13 Hz oscillating frequency and at a pressure setting of 2 cm H2O. The treatment duration was 25 minutes, and the participants remained in a sitting position.

HFCWO only

Subjects received HFCWO intervention twice a week for a period of 8 weeks

Group Type ACTIVE_COMPARATOR

HFCWO

Intervention Type DEVICE

Subjects received the interventions twice a week for 8 weeks. The HFCWO was delivered by a respiratory therapist using a percussive vest at 10-13 Hz oscillating frequency and at a pressure setting of 2 cm H2O. The treatment duration was 25 minutes, and the participants remained in a sitting position.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A vertical vibration platform PowerVibe Zen Pro 5900

Subjects received the interventions twice a week for 8 weeks. HFCWO+WBVT group received additional 30 minutes WBVT treatment. In every WBVT session, three rounds of 3 minutes of vibration (amplitude: 2 mm; frequency: 20 Hz) were provided, with a 60-second rest between rounds.

Intervention Type DEVICE

HFCWO

Subjects received the interventions twice a week for 8 weeks. The HFCWO was delivered by a respiratory therapist using a percussive vest at 10-13 Hz oscillating frequency and at a pressure setting of 2 cm H2O. The treatment duration was 25 minutes, and the participants remained in a sitting position.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Confirmed diagnosis of COPD at the outpatient thoracic medicine clinic
* Need HFCWO as judged by the doctor

Exclusion Criteria

* Acute COPD exacerbation within the previous 4 weeks,
* Contraindication for WBVT (e.g., artificial joint replacement, a history of deep vein thrombosis, or known aortic aneurysm)
* Inability to perform squatting exercises
* Acute disc disease
* Inability to complete the 6MWT

Minimum Eligible Age

35 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No